Dry Macular Degeneration

Also known as: Geographic Atrophy (GA) / Macular Degeneration, Dry / Atrophy, Geographic / Geographic Atrophy / Nonexudative age-related macular degeneration / Dry age-related macular degeneration

Drug	Drug Name	Drug Description
DB15165	Avacincaptad pegol	An RNA aptamer inhibiting the complement C5 indicated for the treatment of geographic atrophy secondary to age-related macular degeneration.

Drug	Drug Name	Target	Type
DB15165	Avacincaptad pegol	Complement C5	target

Drug	Drug Name	Phase	Status	Count
DB16694	Pegcetacoplan	Not Available	Recruiting	1
DB01270	Ranibizumab	Not Available	Unknown Status	1
DB12608	Emixustat	1	Completed	1
DB18860	Galegenimab	1	Completed	1
DB11826	Lampalizumab	1	Completed	1
DB18239	ONL-1204	1	Completed	1
DB16694	Pegcetacoplan	1	Completed	1
DB01024	Mycophenolic acid	1 / 2	Recruiting	1
DB00877	Sirolimus	1 / 2	Completed	1
DB00864	Tacrolimus	1 / 2	Recruiting	1
DB00484	Brimonidine	2	Terminated	1
DB15401	Danicopan	2	Active Not Recruiting	1
DB12608	Emixustat	2	Completed	1
DB05076	Fenretinide	2	Completed	1
DB18860	Galegenimab	2	Terminated	2
DB11826	Lampalizumab	2	Completed	2
DB11826	Lampalizumab	2	Terminated	1
DB00281	Lidocaine	2	Terminated	1
DB00331	Metformin	2	Completed	1
DB05650	OT-551	2	Completed	1
DB17955	Palucorcel	2	Completed	1
DB17955	Palucorcel	2	Withdrawn	1
DB16694	Pegcetacoplan	2	Completed	1
DB00635	Prednisone	2	Recruiting	1
DB00877	Sirolimus	2	Terminated	1
DB11926	Tesidolumab	2	Completed	2
DB00620	Triamcinolone	2	Recruiting	1
DB09145	Water	2	Completed	1
DB15165	Avacincaptad pegol	2 / 3	Completed	1
DB00254	Doxycycline	2 / 3	Completed	1
DB12608	Emixustat	2 / 3	Completed	1
DB15165	Avacincaptad pegol	3	Active Not Recruiting	1
DB15165	Avacincaptad pegol	3	Completed	1
DB16121	Cemdisiran	3	Not Yet Recruiting	1
DB18468	Gildeuretinol	3	Active Not Recruiting	1
DB11826	Lampalizumab	3	Terminated	3
DB16694	Pegcetacoplan	3	Completed	2
DB15218	Pozelimab	3	Not Yet Recruiting	1
DB17832	Tinlarebant	3	Recruiting	1
DB00162	Vitamin A	3	Active Not Recruiting	1